HB 1034 – Maryland
Status: EnactedYear Introduced: 2021
Link: http://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1034?ys=2021RS
Repealing the date by which the Prescription Drug Affordability Board is required to submit a certain plan of action regarding the establishment of a process for setting the upper payment limits for certain prescription drug products to the Legislative Policy Committee of the General Assembly.
Key Issues:
PHARMACEUTICALS
Drug Pricing
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found